In the latest Thematic Insights report, we look at what companies must do under the Australian drug regulator to bring a new product to market.
CLICK TO DOWNLOAD REPORT
Mesoblast has been featured in the latest Thematic Insights Report - Download now!
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.52 |
Change
0.055(3.77%) |
Mkt cap ! $1.724B | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.54 | $1.45 | $4.939M | 3.300M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 7910 | $1.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.52 | 22497 | 4 |
View Market Depth
| Last trade - 14.12pm 12/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |